Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas

NCT05809830 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Advanced Soft-tissue Sarcoma

Interventions

DRUG: LB-100 plus Doxorrubicin
DRUG: Doxorubicin

Sponsor

Grupo Espanol de Investigacion en Sarcomas